Evaluating Opportunities to Expand Oncology Franchise

A leading biopharmaceutical manufacturer wanted to explore opportunities to develop its oncology franchise. Analysis Group worked with internal experts as well as leading US and EU oncologists to establish and document successive criteria used to filter and prioritize more than 1,000 pipeline molecules. We prioritized therapeutic areas into categories based on potential, time horizon, and risk. We identified a small number of promising molecules and company candidates. The client decided to pursue several of these opportunities to continue to grow its franchise.